The participants discussed the latest developments under ABDM that shall enable true interoperability in the health sector and how effective adoption of ABDM can pave the way towards Universal Health Coverage
The company currently supplies one product to the US market that contributes low- single digit revenue to Jubilant Pharmova revenue
On the Capex front, the company has invested Rs. 416 crore in the first half and it is broadly in line with our guidance for the two years around Rs. 2,000 crore across all the subsidiaries and divisions
CGHS would give robust coverage to pensioners and with new innovations and practices
This new initiative will cater to the increasing number of patients in Karnataka in need of heart and lung Failure management and transplant
In the next six months, the program aims to screen 4,000 women from underprivileged communities in and around Mathura
The second day of Arogya Manthan 2022 had panel discussions with eminent thought leaders from relevant public and private sector organizations
The country has been witnessing a progressive reduction in IMR, U5MR and NMR
This newly launched institute will be the centre of excellence in the treatment of all cancers under a single roof.
iNCOVACC was developed in partnership with Washington University St. Louis, which had designed and developed the recombinant adenoviral vectored constructs and evaluated them in preclinical studies for efficacy
Subscribe To Our Newsletter & Stay Updated
